Product
Silymarin
4 clinical trials
6 indications
Indication
Rheumatoid ArthritisIndication
Psoriatic ArthritisIndication
PsoriasisIndication
Colorectal CancerIndication
Atrial Fibrillation New OnsetIndication
Type 2 Diabetes MellitusClinical trial
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases, a Double-blind Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
The Possible Anticancer Effect of Silymarin in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy.Status: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
The Effect of Silymarin on the Prevention of Atrial Fibrillation After Coronary Artery Bypass Graft SurgeryStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Evaluating the Outcome of Silymarin as an Adjunct Therapy to Renin-Angiotensin System Inhibitors in Proteinuric Type 2 Diabetic PatientsStatus: Completed, Estimated PCD: 2023-07-10